Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.
about
Pseudovirions as vehicles for the delivery of siRNAStealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialMammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescenceNanoparticles: pharmacological and toxicological significanceAdvances and Challenges of Liposome Assisted Drug DeliveryDrug carriers based on highly protein-resistant materials for prolonged in vivo circulation timeTherapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisBreast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and TechnologiesNanoemulsions in translational research-opportunities and challenges in targeted cancer therapyTargeted nanotechnology for cancer imaging.Polysaccharide nanosystems for future progress in cardiovascular pathologiesNanostructured lipid carriers: a potential drug carrier for cancer chemotherapyStealth Properties to Improve Therapeutic Efficacy of Drug NanocarriersPre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategyNanoparticles: Is Toxicity a Concern?Stealth nanotubes: strategies of shielding carbon nanotubes to evade opsonization and improve biodistributionNanoparticle Uptake: The Phagocyte ProblemFacilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticlesEncapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery.Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.In vitro measurement of attenuation and nonlinear scattering from echogenic liposomes.Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes.The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfacesTargeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.Loading PEG-catalase into filamentous and spherical polymer nanocarriers.Targeted delivery of therapeutics to endothelium.Nanoprobes with near-infrared persistent luminescence for in vivo imaging.Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functionsIn vivo tumor cell targeting with "click" nanoparticles.Collision-induced dissociation study of poly(2-ethyl-2-oxazoline) using survival yields and breakdown curves.Enhanced localization of anticancer drug in tumor tissue using polyethylenimine-conjugated cationic liposomesNanomedicine in the diagnosis and therapy of neurodegenerative disorders.Stimuli-responsive liposome fusion mediated by gold nanoparticles.Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes.Targeted Nanodelivery of Drugs and DiagnosticsEffect of Surface Modification on the In vitro Protein Adsorption and Cell Cytotoxicity of Vinorelbine Nanoparticles.Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrinMitigation of quantum dot cytotoxicity by microencapsulationDrug transport to brain with targeted nanoparticles.Next generation delivery system for proteins and genes of therapeutic purpose: why and how?
P2860
Q24634231-3A1D2712-1553-410D-8F80-D1BABB8D5640Q24657256-3E97E95C-C0A8-4BA1-94E8-E1EC9ADF325BQ24676577-21D07D1C-F0FF-43DC-A153-AD23C50834DCQ24681563-76B8AC81-FBEA-4043-8EE9-FE3D5A39F25AQ26773160-035E9549-B4D2-41D0-91EF-F1F75B93D0D4Q26774341-C4E9CC64-31F7-491C-9FEC-41334BEB3224Q26782089-114C23A7-709A-4ABC-9994-D975C9CD489DQ26783705-C59A5ED9-1898-4F30-85F9-CE23A6EC82CFQ26858849-55C485A4-401B-46DB-B2C5-E0323183A14EQ27010317-C47B34A0-F557-490B-8121-1ADCEAB24D6FQ27025494-060CD165-CD11-47C2-8531-2D1916FF3933Q27027328-B9017C07-4B6C-4CFE-AA04-B595EFF63565Q27496024-2EE93E7F-79E2-4DEB-9D0E-9B9A37FF10BCQ28081577-D46F7FA6-81B5-45F7-A14A-E24CA769DBACQ28385921-4C047773-2F9E-4BDB-9FEC-75424C767623Q28386169-C17B1517-3FDA-4A12-806B-81B107B17FF7Q28395287-01DE0894-BDA1-4AC0-BF00-29E94DA0018EQ28474651-87EB7403-346A-49D7-B77F-C1C55606C562Q30409097-C050F2E9-C0E4-40FF-A5DB-68C948109B62Q30439353-1531EF9A-AC51-426F-87EE-9C5561A586DDQ30444512-1F03CB5A-4A47-4D4A-9AEB-BAD3CDDCDEA6Q30449753-80E9AAEB-8506-47F9-9904-09C423F430F0Q30464013-7E46CD0D-B659-4A8E-9F42-5860EBE5CF6EQ30466992-442FD26C-B213-4E7E-9503-FE697BFC7125Q30475568-9952FB45-5A3F-4DDB-A9AA-FFB9501534F9Q30475849-38430075-2E6D-40CF-B025-9FDC2B8E8ACBQ30479577-9F0BE9BE-3092-4818-BE15-FEC5DDADA084Q30543404-CB7B0018-BC30-4902-9836-8EC9A1ED96D1Q33350022-79B4D15E-6F55-42CE-B25C-0D349B1C81F6Q33456831-6DD0940D-5D31-4E62-9D28-ABA8C54DAF9FQ33582328-651FFCC9-3D15-40BD-B82B-D41C4AE7548CQ33726019-170ED6E2-E34D-42BE-BF60-90A035251A2EQ33814671-D436F217-26F9-4BBE-A6BB-EEA3FE60FC54Q33838871-66C0B12D-7BE3-4C0E-86B6-DB6F0F82ECA6Q33900258-462C9018-9AAF-4EEC-AFF8-8EF1F02564D2Q33900389-EB1B0DFC-AEF0-4A57-B123-CB2884CA72ACQ33947942-5875BE02-3C2A-4C63-BD4E-23197D07B8EFQ33981469-5040F972-0FAF-45CD-8211-D8711998B711Q33985140-4057334F-8110-4F72-B6F5-76F725E52150Q34003800-5AD11DAC-35B0-41DE-B4D3-FC26A1AC54BA
P2860
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Stealth liposomes and long cir ...... nd protein-binding properties.
@ast
Stealth liposomes and long cir ...... nd protein-binding properties.
@en
type
label
Stealth liposomes and long cir ...... nd protein-binding properties.
@ast
Stealth liposomes and long cir ...... nd protein-binding properties.
@en
prefLabel
Stealth liposomes and long cir ...... nd protein-binding properties.
@ast
Stealth liposomes and long cir ...... nd protein-binding properties.
@en
P1476
Stealth liposomes and long cir ...... nd protein-binding properties.
@en
P2093
P304
P356
10.1016/S0163-7827(03)00033-X
P577
2003-11-01T00:00:00Z